NYSE - Nasdaq Real Time Price • USD
Laboratory Corporation of America Holdings (LH)
As of 11:49 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 18 | 18 |
| Avg. Estimate | 3.48 | 3.84 | 14.82 | 16.04 |
| Low Estimate | 3.3 | 3.75 | 14.45 | 15.38 |
| High Estimate | 3.59 | 3.97 | 15 | 16.82 |
| Year Ago EPS | 3.46 | 3.42 | 13.56 | 14.82 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 17 | 17 |
| Avg. Estimate | 3.12B | 3.2B | 12.76B | 13.31B |
| Low Estimate | 3.02B | 3.18B | 12.63B | 12.9B |
| High Estimate | 3.16B | 3.25B | 12.83B | 13.55B |
| Year Ago Sales | 3.78B | 3.03B | 12.16B | 12.76B |
| Sales Growth (year/est) | -17.50% | 5.40% | 4.90% | 4.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 3.96 | 3.53 | 3.33 | 3.26 |
| EPS Actual | 3.46 | 3.42 | 3.38 | 3.3 |
| Difference | -0.5 | -0.11 | 0.05 | 0.04 |
| Surprise % | -12.60% | -3.10% | 1.50% | 1.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 3.48 | 3.84 | 14.82 | 16.04 |
| 7 Days Ago | 3.48 | 3.84 | 14.82 | 16.04 |
| 30 Days Ago | 3.51 | 3.81 | 14.82 | 16.05 |
| 60 Days Ago | 3.51 | 3.78 | 14.8 | 16.07 |
| 90 Days Ago | 3.62 | 3.68 | 14.61 | 15.98 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 2 | -- | -- |
| Up Last 30 Days | -- | 3 | 2 | 4 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 2 | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | LH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 0.60% | -- | -- | 0.30% |
| Next Qtr. | 12.30% | -- | -- | 9.80% |
| Current Year | 9.30% | -- | -- | 4.50% |
| Next Year | 8.20% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 8.36% | -- | -- | 11.06% |
| Past 5 Years (per annum) | 8.18% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | Argus Research: Hold to Buy | 3/25/2024 |
| Initiated | Leerink Partners: Outperform | 2/26/2024 |
| Initiated | Evercore ISI Group: In-Line | 2/9/2024 |
| Initiated | Barclays: Equal-Weight | 1/3/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 11/17/2023 |
| Maintains | Mizuho: Buy to Buy | 10/31/2023 |
Related Tickers
DGX Quest Diagnostics Incorporated
137.60
+0.66%
IQV IQVIA Holdings Inc.
239.22
+0.25%
ICLR ICON Public Limited Company
306.33
-0.04%
WAT Waters Corporation
306.43
-2.19%
IDXX IDEXX Laboratories, Inc.
493.84
+0.01%
A Agilent Technologies, Inc.
136.90
-1.65%
QGEN Qiagen N.V.
41.37
-1.24%
CRL Charles River Laboratories International, Inc.
238.34
-0.75%
NTRA Natera, Inc.
92.55
+1.65%
MTD Mettler-Toledo International Inc.
1,227.92
-1.08%